Capstone Investment Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,419
| Closed | -$465K | – | 871 |
|
|
2024
Q4 | $465K | Sell |
1,419
-621
| -30% | -$203K | ﹤0.01% | 529 |
|
|
2024
Q3 | $612K | Sell |
2,040
-731
| -26% | -$219K | ﹤0.01% | 384 |
|
|
2024
Q2 | $913K | Buy |
2,771
+785
| +40% | +$259K | ﹤0.01% | 361 |
|
|
2024
Q1 | $786K | Sell |
1,986
-272
| -12% | -$108K | ﹤0.01% | 636 |
|
|
2023
Q4 | $795K | Buy |
+2,258
| New | +$795K | ﹤0.01% | 392 |
|
|
2023
Q3 | – | Sell |
-883
| Closed | -$338K | – | 1320 |
|
|
2023
Q2 | $338K | Buy |
+883
| New | +$338K | ﹤0.01% | 547 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 744 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 833 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1160 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1168 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1097 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1094 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1047 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1003 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 816 |
|
|
2018
Q1 | – | Sell |
-3,760
| Closed | -$370K | – | 412 |
|
|
2017
Q4 | $370K | Buy |
+3,760
| New | +$370K | 0.01% | 238 |
|
|
2017
Q3 | – | Sell |
-21,760
| Closed | -$2.06M | – | 642 |
|
|
2017
Q2 | $2.06M | Buy |
21,760
+2,756
| +15% | +$260K | 0.06% | 198 |
|
|
2017
Q1 | $1.55M | Buy |
+19,004
| New | +$1.55M | 0.04% | 240 |
|
|
2016
Q4 | – | Sell |
-18,995
| Closed | -$1.42M | – | 914 |
|
|
2016
Q3 | $1.42M | Buy |
+18,995
| New | +$1.42M | 0.03% | 231 |
|